UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 4, 2007
GENTA INCORPORATED
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
|
0-19635 |
33-0326866 |
|
(Commission File Number) |
(IRS Employer Identification No.) |
|
200 Connell Drive |
07922 |
|
(Address of Principal Executive Offices) |
(Zip Code) |
(908) 286-9800
(Registrant’s Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
|
Item 8.01 Other Events.
On April 4, 2007, Genta Incorporated, (the Company), issued a press release announcing that the Company has filed a formal appeal of the recent non-approvable decision by the Food and Drug Administration (FDA) for the Company’s New Drug Application (NDA) for Genasense® (oblimersen sodium) Injection. The NDA proposed the use of Genasense in combination with chemotherapy for treatment of patients with relapsed or refractory chronic lymphocytic leukemia (CLL).
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit |
Description |
|
|
99.1 |
Press Release of the Company dated April 4, 2007 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
GENTA INCORPORATED |
||
|
Date: April 4, 2007 |
By: |
/s/ RICHARD J. MORAN |
|
|
|
|
Name: |
Richard J. Moran |
|
|
|
Title: |
Senior Vice President, |
EXHIBIT INDEX
|
Exhibit |
Description |
Sequentially |
|
99.1 |
Press Release of the Company dated April 4, 2007 |
|